Russell Investments Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$135M Buy
1,070,731
+2,894
+0.3% +$381K 0.12% 162
2026
Q1
$148M Sell
1,067,837
-193,459
-15% -$27.1M 0.16% 123
2025
Q4
$155M Buy
1,261,296
+50,024
+4% +$6.08M 0.17% 115
2025
Q3
$135M Sell
1,211,272
-49,215
-4% -$5.59M 0.15% 130
2025
Q2
$140M Buy
1,260,487
+10,620
+0.8% +$1.13M 0.18% 112
2025
Q1
$140M Buy
1,249,867
+250,538
+25% +$25.9M 0.19% 103
2024
Q4
$92.3M Buy
999,329
+70,214
+8% +$6.32M 0.13% 156
2024
Q3
$77.9M Sell
929,115
-145,756
-14% -$11.1M 0.11% 199
2024
Q2
$73.8M Buy
1,074,871
+47,891
+5% +$3.2M 0.12% 178
2024
Q1
$75.2M Sell
1,026,980
-55,922
-5% -$4.3M 0.12% 182
2023
Q4
$87.7M Sell
1,082,902
-209,199
-16% -$16.3M 0.16% 135
2023
Q3
$96.9M Buy
1,292,101
+45,984
+4% +$3.54M 0.19% 107
2023
Q2
$95.9M Sell
1,246,117
-234,711
-16% -$18.7M 0.19% 106
2023
Q1
$122M Sell
1,480,828
-9,457
-0.6% -$783K 0.24% 82
2022
Q4
$128M Sell
1,490,285
-287,801
-16% -$22.8M 0.26% 70
2022
Q3
$110M Buy
1,778,086
+44,171
+3% +$2.79M 0.24% 77
2022
Q2
$107M Buy
1,733,915
+203,842
+13% +$12.6M 0.22% 86
2022
Q1
$91M Buy
1,530,073
+447,449
+41% +$28.6M 0.16% 150
2021
Q4
$78.7M Sell
1,082,624
-21,495
-2% -$1.48M 0.13% 190
2021
Q3
$77.5M Sell
1,104,119
-127,745
-10% -$8.97M 0.13% 175
2021
Q2
$84.6M Buy
1,231,864
+50,431
+4% +$3.37M 0.14% 159
2021
Q1
$76.6M Sell
1,181,433
-191,659
-14% -$12.4M 0.14% 163
2020
Q4
$79.1M Buy
1,373,092
+12,570
+0.9% +$758K 0.16% 140
2020
Q3
$85.4M Buy
1,360,522
+216,712
+19% +$15M 0.18% 114
2020
Q2
$86.9M Sell
1,143,810
-1,934
-0.2% -$148K 0.19% 107
2020
Q1
$86.1M Sell
1,145,744
-1,349,280
-54% -$93.2M 0.22% 93
2019
Q4
$162M Buy
2,495,024
+11,814
+0.5% +$769K 0.3% 52
2019
Q3
$157M Buy
2,483,210
+125,993
+5% +$8.24M 0.3% 51
2019
Q2
$159M Buy
2,357,217
+120,030
+5% +$7.9M 0.3% 56
2019
Q1
$144M Buy
2,237,187
+255,632
+13% +$17M 0.27% 69
2018
Q4
$123M Buy
1,981,555
+6,785
+0.3% +$474K 0.28% 65
2018
Q3
$152M Buy
1,974,770
+95,171
+5% +$7.19M 0.29% 61
2018
Q2
$133M Sell
1,879,599
-168,881
-8% -$11.9M 0.28% 59
2018
Q1
$154M Sell
2,048,480
-312,699
-13% -$24.9M 0.26% 66
2017
Q4
$171M Buy
2,361,179
+912,621
+63% +$69.3M 0.29% 60
2017
Q3
$117M Buy
1,448,558
+401,367
+38% +$30.7M 0.2% 99
2017
Q2
$74.1M Sell
1,047,191
-67,933
-6% -$4.52M 0.13% 171
2017
Q1
$75.7M Sell
1,115,124
-30,580
-3% -$2.15M 0.14% 166
2016
Q4
$82.6M Buy
+1,145,704
New +$85.2M 0.16% 141

Other funds holding GILD

Russell Investments Group's GILD Position: Q2 2026 in Review

Russell Investments Group increased its Gilead Sciences (GILD) stake by 0.27% in Q2 2026, buying an estimated $381K and bringing the position to 1,070,731 shares worth $135M. The position accounts for 0.12% of the portfolio, ranked #162.

Russell Investments Group first reported a position in GILD in Q4 2016 and has held it in 39 quarters since. The position peaked at $171M in Q4 2017. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Russell Investments Group held 1,070,731 shares of Gilead Sciences worth $135M as of Q2 2026.
  • Russell Investments Group bought 2,894 Gilead Sciences shares in Q2 2026, an estimated $381K.
  • Gilead Sciences made up 0.12% of Russell Investments Group's portfolio in Q2 2026, its #162 holding.
  • Russell Investments Group first reported a position in Gilead Sciences in Q4 2016 and has held it in 39 quarters since.
  • Russell Investments Group's Gilead Sciences position peaked at $171M in Q4 2017.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.